Celtarys offers highly specific GLP1R fluorescent ligands, extensively tested in various cell lines, making them ideal for studying the GLP-1 receptor in contexts such as type 2 diabetes, weight loss, and kidney disease.

Our ligands, developed by Johannes Broichhagen (Max Planck Institute for Medical Research, Heidelberg, Germany and Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany) and David J. Hodson (University of Birmingham), and exclusively licensed to Celtarys, have been shown to be highly effective in studying the GLP-1 receptor and related proteins, including glucagon-like peptide and GLP-1 receptor agonists. They are particularly useful for live cell imaging, receptor activation assays, and studying downstream effects, blood sugar regulation, and cell surface signaling pathways.

At Celtarys, we are committed to providing you with the best products on the market for studying G protein-coupled receptors, and we are constantly developing new solutions to meet your needs.

Do you want more information?

We are ready to support your challenges

Contact us
0